Literature DB >> 9421799

Proposed link between Helicobacter pylori and sudden infant death syndrome.

C P Pattison1, B J Marshall.   

Abstract

Helicobacter pylori may be linked to sudden infant death syndrome (SIDS) through synthesis of inflammatory cytokines, particularly interleukin-1, which can produce fever, activation of the immune system, and increased deep sleep. A relatively minor respiratory or enteric infection, together with overwrapping and prone sleep position could then induce terminal hypoxemia. Alternatively, H. pylori produces large amounts of urease which, if aspirated in gastric juice, could reach the alveolae, react with plasma urea, and produce ammonia toxicity leading to respiratory arrest. Epidemiological similarities between H. pylori and SIDS are presented along with possible transmission mechanisms for H. pylori which support this hypothesis.

Entities:  

Mesh:

Year:  1997        PMID: 9421799     DOI: 10.1016/s0306-9877(97)90080-3

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Sudden infant death syndrome, long QT interval, and Helicobacter pylori.

Authors:  J R Kerr
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

Review 2.  Extradigestive manifestations of Helicobacter pylori gastric infection.

Authors:  A Gasbarrini; F Franceschi; A Armuzzi; V Ojetti; M Candelli; E S Torre; A De Lorenzo; M Anti; S Pretolani; G Gasbarrini
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 3.  Helicobacter pylori infection in pediatric patients.

Authors:  V Tolia
Journal:  Curr Gastroenterol Rep       Date:  1999-08

4.  An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection.

Authors:  J R Kerr; A Al-Khattaf; A J Barson; J P Burnie
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

5.  Real-time quantitative PCR assay for the detection of Helicobacter pylori: no association with sudden infant death syndrome.

Authors:  Brigitte Loddenkötter; Karsten Becker; Carsten Hohoff; Bernd Brinkmann; Thomas Bajanowski
Journal:  Int J Legal Med       Date:  2005-03-10       Impact factor: 2.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.